Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Dementia patient over-medicated and bruised when he died, widow tells Australian aged care inquiry

Published 02/11/2019, 01:51 AM
Updated 02/11/2019, 01:51 AM
© Reuters. Barbara Spriggs and son Clive Spriggs speak to the media after giving evidence at the Royal Commission into Aged Care, Commonwealth Courts in Adelaide

By Colin Packham

SYDNEY (Reuters) - An elderly man suffering Parkinson's Disease and dementia was given 10 times his medication and had unexplained bruising when he died at an Australian aged care facility, his widow told an inquiry into the A$20 billion ($14 billion) aged care sector.

A Royal Commission inquiry into Australia's aged care industry began hearings on Monday, after a slew of reports of dementia patients being bound in restraints, assaults on patients, overdosing, predatory pricing and poor care.

The inquiry's first witness Barbara Spriggs, whose husband died in 2016 at the Oakden Older Persons Mental Health Service in South Australia, said she does not know why her husband died.

"He had been over-medicated, had severe bruising, was dehydrated and suffering from pneumonia. To this day, I don't know what happened to Bob," Spriggs told in the inquiry in Adelaide, in the state of South Australia.

Spriggs said the center was in an obvious state of disrepair but her family had little choice in keeping her husband there as she was unable to care for him at home.

"The facility at Oakden was like something out of the 19th century," she said.

"Bob was lying on a bed with just a sheet underneath him, there was no seat on the toilet, only paper towels in the bathroom. It was like a prison."

Shares in the four largest listed operators, Aveo Group, Estia Health Ltd, Japara Healthcare Ltd and Regis Healthcare Ltd, previously seen as an attractive exposure to Australia's ageing population, have plunged since the inquiry was announced last September.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

They have each shed at least a fifth of their value, wiping almost A$1 billion from their cumulative market capitalization.

Unlisted players, such as Bupa Aged Care Holdings Pty Ltd, the country's largest aged care operator by market share, have also been the subject of upsetting revelations and are in damage control.

The Royal Commission, which will sit for 16 rounds of public hearings, is expected to hear harrowing testimony from the families of aged care patients, as well as testimony from industry leaders.

Counsel assisting the Royal Commission, Peter Gray, said he had received responses from about 900 of Australia's 2,000 approved aged care providers, along with more than 800 submissions from the public. Many of the public submissions directly related to substandard or unsafe care.

The government-sanctioned inquiry is due to provide an interim report by Oct. 31 and a final report before the end of April 2020.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.